-
Uncategorized2 months ago
FDA bolsters bespoke therapy framework with new draft safety guidelines
FDA bolsters bespoke therapy framework with new draft safety guidelines
-
Uncategorized2 months ago
FDA asks for more data on Lilly’s Foundayo to assess heart, liver risks
The FDA is concerned that Eli Lilly’s newly approved obesity pill Foundayo might come with a risk for major cardiovascular events and liver damage, and has...
-
Uncategorized2 months ago
Replimune looks ahead as repeat CRL speeds the company’s decline
Replimune’s second complete response letter for its cancer therapy last week is already leading to multiple rounds of layoffs and existential questions about the company’s future...
-
Uncategorized2 months agoSTAT+: Congress returns to a packed health care agenda
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized2 months agoLaigo Bio announces new CSO as part of board appointments
Biotechnology company Laigo Bio has appointed Dr Richard Sainson as Chief Scientific Officer as part of a swathe of board appointments. The company, which specialises in autoimmune and inflammatory...
-
Uncategorized2 months agoTravere wins long-awaited approval for kidney disease drug
The clearance of Filspari in a condition known as FSGS ends a winding regulatory journey and unlocks a revenue opportunity believed to be worth more than...
-
Uncategorized2 months ago
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough,...
-
Uncategorized2 months ago
Revolution Medicines leads latest wave of stock offerings, totaling $1.5B
Another stock offering blitz is adding more fuel to biotech investors’ belief in the sector. Revolution Medicines anchored Monday’s offering surge, while Spyre Therapeutics and Allogene...
-
Uncategorized2 months ago
AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development
AWS has now unveiled Amazon Bio Discovery, an AI platform that grants researchers direct access to a broad library of biological foundation models that can be...
-
Uncategorized2 months ago
Bonus: Q1 2026 Job Market Update
In this bonus episode, BioSpace’s Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q1 job market performance and what...
Amgen shores up Tavneos’ FDA defense with Duke data analysis
